Frontlight ResearchEarly access
CompletedNo phase
Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.
Key facts
- Who runs it
- Acibadem University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 102 people enrolled
- Started
- 1 Sept 2022
- Ended
- 30 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Tranexamic acid
- Saline
- Record updated
- 24 May 2024
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Healthy volunteer female patients over the age of 18 who will undergo laparoscopic myomectomy in our clinic will be included in our study
Who cannot take part
- Patients who are planned to undergo different surgery along with myomectomy
- Those with a diagnosis and suspicion of malignancy
- Those with a history of thromboembolic disease
- Those with cardiac, hepatic or renal disease
- Those allergic to tranexamic acid
- Those who use drugs or diseases that may affect coagulation (serum creatinine > 1.5 mg/dL)
- Those with a body mass index of 30 and above
- Patients with abnormal coagulation test results
- Patients using anticoagulants
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate the effect of intravenous tranexamic acid plus intramyometrial desmopressin administration on perioperative blood loss and blood transfusion need in laparoscopic myomectomy operation.
The 2 groups in the trial
- Tranexamic acid and group (Group I)Existing treatment, for comparison
In Group I, 1 gram of tranexamic acid will be diluted into 100 ml of saline solution and administered at a rate of 100 ml/hr 10 minutes before the skin incision time.
Treatment: Tranexamic acid
- Saline group (Group II)Placebo, for comparison
Group II placebo will be administered to the control group, and 100 ml of saline solution will be administered at a rate of 100 ml/hr 10 minutes before the skin incision time.
Treatment: Saline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Intravenous Tranexamic Acid Plus Intramyometrial Desmopressin on Blood Loss During Laparoscopic Myomectomy: Randomized, Double-blind, Placebo-controlled Trial
- Record updated
- 24 May 2024